Decellularised extracellular matrix-derived peptides from neural retina and retinal pigment epithelium enhance the expression of synaptic markers and light responsiveness of human pluripotent stem cell derived retinal organoids.


Journal

Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316

Informations de publication

Date de publication:
04 2019
Historique:
received: 23 10 2018
revised: 11 01 2019
accepted: 20 01 2019
pubmed: 10 2 2019
medline: 4 7 2020
entrez: 10 2 2019
Statut: ppublish

Résumé

Tissue specific extracellular matrices (ECM) provide structural support and enable access to molecular signals and metabolites, which are essential for directing stem cell renewal and differentiation. To mimic this phenomenon in vitro, tissue decellularisation approaches have been developed, resulting in the generation of natural ECM scaffolds that have comparable physical and biochemical properties of the natural tissues and are currently gaining traction in tissue engineering and regenerative therapies due to the ease of standardised production, and constant availability. In this manuscript we report the successful generation of decellularised ECM-derived peptides from neural retina (decel NR) and retinal pigment epithelium (decel RPE), and their impact on differentiation of human pluripotent stem cells (hPSCs) to retinal organoids. We show that culture media supplementation with decel RPE and RPE-conditioned media (CM RPE) significantly increases the generation of rod photoreceptors, whilst addition of decel NR and decel RPE significantly enhances ribbon synapse marker expression and the light responsiveness of retinal organoids. Photoreceptor maturation, formation of correct synapses between retinal cells and recording of robust light responses from hPSC-derived retinal organoids remain unresolved challenges for the field of regenerative medicine. Enhanced rod photoreceptor differentiation, synaptogenesis and light response in response to addition of decellularised matrices from RPE and neural retina as shown herein provide a novel and substantial advance in generation of retinal organoids for drug screening, tissue engineering and regenerative medicine.

Identifiants

pubmed: 30738336
pii: S0142-9612(19)30049-3
doi: 10.1016/j.biomaterials.2019.01.028
pii:
doi:

Substances chimiques

Biomarkers 0
Culture Media, Conditioned 0
Peptides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

63-75

Subventions

Organisme : Medical Research Council
ID : MC_PC_15030
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N005872/1
Pays : United Kingdom
Organisme : National Centre for the Replacement, Refinement and Reduction of Animals in Research
ID : NC/C016106/1
Pays : United Kingdom

Informations de copyright

Crown Copyright © 2019. Published by Elsevier Ltd. All rights reserved.

Auteurs

Birthe Dorgau (B)

Institute of Genetic Medicine, Newcastle University, UK.

Majed Felemban (M)

Institute of Genetic Medicine, Newcastle University, UK.

Gerrit Hilgen (G)

Institute of Neuroscience, Newcastle University, UK.

Martin Kiening (M)

Institute of Genetic Medicine, Newcastle University, UK.

Darin Zerti (D)

Institute of Genetic Medicine, Newcastle University, UK.

Nicola Claire Hunt (NC)

Institute of Genetic Medicine, Newcastle University, UK.

Mary Doherty (M)

University of the Highlands and Islands, UK.

Phil Whitfield (P)

University of the Highlands and Islands, UK.

Dean Hallam (D)

Institute of Genetic Medicine, Newcastle University, UK.

Kathryn White (K)

EM Research Services, Newcastle University, UK.

Yuchun Ding (Y)

Interdisciplinary Computing and Complex Biosystems (ICOS) Research Group, Newcastle University, UK.

Natalio Krasnogor (N)

Interdisciplinary Computing and Complex Biosystems (ICOS) Research Group, Newcastle University, UK.

Jumana Al-Aama (J)

Department of Genetic Medicine and Princess Al-Jawhara Center of Excellence in Research of Hereditary Disorders, Faculty of Medicine, King Abdulaziz University, Saudi Arabia.

Hani Z Asfour (HZ)

Department of Medical Microbiology and Parasitology, Faculty of Medicine, Princess Al-Jawhara Center of Excellence in Research o Hereditary Disorders, King Abdulaziz University, Jeddah, Saudi Arabia.

Evelyne Sernagor (E)

Institute of Neuroscience, Newcastle University, UK.

Majlinda Lako (M)

Institute of Genetic Medicine, Newcastle University, UK. Electronic address: majlinda.lako@ncl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH